Dr Jacob Friedman, MD | |
101 Delta Park Dr, Shelby, NC 28150-3575 | |
(704) 323-2000 | |
Not Available |
Full Name | Dr Jacob Friedman |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 22 Years |
Location | 101 Delta Park Dr, Shelby, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922000561 | NPI | - | NPPES |
89132F0 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 200300459 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kindred At Home | Shelby, NC | Home health agency |
Atrium Health Cleveland | Shelby, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Orthocarolina, Pa | 2062316821 | 436 |
News Archive
Aged cheeses pack a punch of nutty, sharp flavor. Before they're fully mature, aged cheeses are either waxed or placed in brine for weeks to create a natural rind. However, the high salt content in brined cheeses deters some consumers.
A recent review describes the role of nanobodies as a new class of recombinant antibodies that are used in the treatment of COVID-19.
A report by researchers at Columbia University's Mailman School of Public Health provides an expanded review of six new air quality regulations proposed or recently adopted by the U.S. Environmental Protection Agency's.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
› Verified 6 days ago
Entity Name | Orthocarolina, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497704217 PECOS PAC ID: 2062316821 Enrollment ID: O20031122000126 |
News Archive
Aged cheeses pack a punch of nutty, sharp flavor. Before they're fully mature, aged cheeses are either waxed or placed in brine for weeks to create a natural rind. However, the high salt content in brined cheeses deters some consumers.
A recent review describes the role of nanobodies as a new class of recombinant antibodies that are used in the treatment of COVID-19.
A report by researchers at Columbia University's Mailman School of Public Health provides an expanded review of six new air quality regulations proposed or recently adopted by the U.S. Environmental Protection Agency's.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jacob Friedman, MD 4601 Park Rd, Suite 300, Charlotte, NC 28209-3239 Ph: (704) 323-2000 | Dr Jacob Friedman, MD 101 Delta Park Dr, Shelby, NC 28150-3575 Ph: (704) 323-2000 |
News Archive
Aged cheeses pack a punch of nutty, sharp flavor. Before they're fully mature, aged cheeses are either waxed or placed in brine for weeks to create a natural rind. However, the high salt content in brined cheeses deters some consumers.
A recent review describes the role of nanobodies as a new class of recombinant antibodies that are used in the treatment of COVID-19.
A report by researchers at Columbia University's Mailman School of Public Health provides an expanded review of six new air quality regulations proposed or recently adopted by the U.S. Environmental Protection Agency's.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
› Verified 6 days ago
Dr. Yves Boudreau, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 Delta Park Dr, Shelby, NC 28150 Phone: 704-323-2000 | |
Dr. Kevin Todd James, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 Delta Park Dr, Shelby, NC 28150 Phone: 704-323-2000 | |
Dr. Bruce Arthur Cox, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Delta Park Dr, Shelby, NC 28150 Phone: 704-323-2000 | |
Dr. Patrick Robert-lawrence Hayes, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Delta Park Dr, Shelby, NC 28150 Phone: 704-323-2000 | |
Dr. William Vincent Stucky, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Delta Park Dr, Shelby, NC 28150 Phone: 704-323-2000 | |
Brian Opalacz, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Delta Park Dr, Shelby, NC 28150 Phone: 704-484-0606 |